Jagsonpal Pharmaceuticals Limited

NSE:JAGSNPHARM.NS

639.65 (INR) • At close December 27, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) INR.

20232022202120202019201820172016201520142013201220112010200920082007
Operating Activities:
Net Income 224.63348.085273.191218.72394.14890.028-116.267143.96740.75316.71725.31318.32774.56892.681105.00198.98551.919
Depreciation & Amortization 16.6312.05415.26210.8611.29810.15810.62319.9430.93627.06928.25427.07625.35822.00920.8512.49816.872
Deferred Income Tax 0-77.626000000000000000
Stock Based Compensation 133.187.65000000000000000
Change In Working Capital 55.3998.743-171.294115.94342.54197.10487.881-61.307-19.56-40.938-26.53425.024-75.138-14.021-87.338107.80411.313
Accounts Receivables 91.54-55.56-29.5587.894-7.03244.034142.59322.77331.9863.321-30.1931.05800000
Inventory 53.190.657-0.176-3.99533.676187.412-38.147-77.816-67.755-24.728-5.20851.478126.63-1.251-4.227115.011107.014
Accounts Payables -89.82-19.62-10.7563.406-1.51127.6781.103-7.44518.57800000000
Other Working Capital 0.5783.266-130.818-31.36217.407-62.02126.02816.50948.195-16.21-21.326-26.454-201.768-12.77-83.111-7.207-95.701
Other Non Cash Items -78.09-2.366-61.178-63.302-35.51611.6932.004-135.01538.25640.13248.1550.06846.042-36.108-29.961-41.132-24.223
Operating Cash Flow 351.66466.54155.981282.224112.47308.983-15.759-32.41590.38542.9875.183120.49570.8364.5618.552178.15555.881
Investing Activities:
Investments In Property Plant And Equipment -2.48-3.176-4.675-4.691-20.68-22.549-38.279-25.792-27.488-5.753-12.752-37.171-53.091-70.088-20.997-84.791-47.245
Acquisitions Net 012.965.810022.5490434.027000000000
Purchases Of Investments -1,354.07-1,032.96-284.486-41.728-113.863000000000000
Sales Maturities Of Investments 1,037.4412.19-5.8100000000000000
Other Investing Activites 73.6734.27927.08223.77626.916-8.2594.568438.7166.5641.110.6073.2313.6920000
Investing Cash Flow -245.48-576.707-262.079-22.643-107.627-8.259-33.711412.924-20.924-4.643-12.145-33.94-49.399-70.088-20.997-84.791-47.245
Financing Activities:
Debt Repayment 00-67.8808.794-45.1513.724-305.646-8.17833.5328.71-15.36762.9267.1170-854.999
Common Stock Issued 56.350000000000000000
Common Stock Repurchased 000-36.9470000000000000
Dividends Paid -130.990-104.79-26.2-13.1-6.55-2.62-3.153-2.62-2.62-13.099-13.099-13.0990000
Other Financing Activities -14.47-3.2265.027-5.135-13.935-8.801-7.105-26.981-53.503-45.109-56.047-53.46-2.12513.09912.768-12.366-95.145
Financing Cash Flow -89.11-4.567-123.038-68.282-9.447-60.502-6.001-335.247-64.301-14.199-40.436-81.9264.127.11712.768-97.366-8.376
Other Information:
Effect Of Forex Changes On Cash 00.003-35.033017.388000-0.001-0.001-0.002-0.002-0.0010000
Net Change In Cash 17.07-114.733-329.136191.299-4.604240.222-55.47145.2625.15924.13722.64.62725.551.5890.323-4.0020.259
Cash At End Of Period 127.6110.531260.293589.429380.742385.346145.124200.595155.333150.174126.034103.43498.8073.7032.1141.7915.793